Cargando…

Carbon footprint impact of the choice of inhalers for asthma and COPD

In the 1990s, metered dose inhalers (MDIs) containing chlorofluorocarbons were replaced with dry-powder inhalers (DPIs) and MDIs containing hydrofluorocarbons (HFCs). While HFCs are not ozone depleting, they are potent greenhouse gases. Annual carbon footprint (CO(2)e), per patient were 17 kg for Re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janson, Christer, Henderson, Richard, Löfdahl, Magnus, Hedberg, Martin, Sharma, Raj, Wilkinson, Alexander J K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929707/ https://www.ncbi.nlm.nih.gov/pubmed/31699805 http://dx.doi.org/10.1136/thoraxjnl-2019-213744

Ejemplares similares

Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis
por: Woodcock, Ashley, et al.
Publicado: (2022)

Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients
por: Ställberg, Björn, et al.
Publicado: (2020)

Evaluation of inhaler technique among patients with asthma and COPD in Yemen
por: Al-Worafi, Yaser M.
Publicado: (2018)

Reducing carbon footprint by switching to reusable soft-mist inhalers
por: Janson, Christer, et al.
Publicado: (2023)

Educational interventions to improve inhaler techniques and their impact on asthma and COPD control: a pilot effectiveness-implementation trial
por: Maricoto, Tiago, et al.
Publicado: (2016)

Translated impact on carbon footprint from choice of inhaled therapy: a Danish scenario
por: Vestbo, Jørgen, et al.
Publicado: (2023)

The carbon footprint of respiratory treatments in Europe and Canada: an observational study from the CARBON programme
por: Janson, Christer, et al.
Publicado: (2022)

Influence of the first wave of COVID-19 on asthma inhaler prescriptions
por: Bloom, C. I., et al.
Publicado: (2021)

Inhaled corticosteroids reduce senescence in endothelial progenitor cells from patients with COPD
por: Paschalaki, Koralia, et al.
Publicado: (2022)

Local variation in low carbon footprint inhalers in pre‐COVID pandemic primary care prescribing guidelines for adult asthma in England and its potential impact
por: Twigg, Adam J., et al.
Publicado: (2022)

Personalising adherence-enhancing interventions using a smart inhaler in patients with COPD: an exploratory cost-effectiveness analysis
por: van Boven, Job F. M., et al.
Publicado: (2018)

Characterization of secondary care for COPD in Sweden
por: Sundh, Josefin, et al.
Publicado: (2017)

The International Society for Children’s Health and the Environment Commits to Reduce Its Carbon Footprint to Safeguard Children’s Health
por: Eskenazi, Brenda, et al.
Publicado: (2020)

Differences in medication adherence are associated with beliefs about medicines in asthma and COPD
por: Brandstetter, Susanne, et al.
Publicado: (2017)

Inhaled corticosteroids in COPD: Personalising the therapeutic choice
por: Shaw, J A, et al.
Publicado: (2018)

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
por: Janson, Christer, et al.
Publicado: (2017)

Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England
por: Wilkinson, Alexander J K, et al.
Publicado: (2019)

Initial inhaler choice in COPD: real-world evidence
por: Jones, Thomas
Publicado: (2019)

A review of the value of innovation in inhalers for COPD and asthma
por: Virchow, Johann Christian, et al.
Publicado: (2015)

Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
por: Ekbom, Emil, et al.
Publicado: (2019)

The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units
por: Sundh, Josefin, et al.
Publicado: (2015)

Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD
por: Kocks, Janwillem W. H., et al.
Publicado: (2018)

Inhalation of Iodine in Asthma
por: Westmoreland, J. G.
Publicado: (1877)

A cross-sectional observational study to assess inhaler technique in Saudi hospitalized patients with asthma and chronic obstructive pulmonary disease
por: Ammari, Maha Al, et al.
Publicado: (2016)

COPD Patients’ Behaviour When Involved in the Choice of Inhaler Device
por: Bivolaru, Sorin, et al.
Publicado: (2023)

A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices
por: van der Palen, Job, et al.
Publicado: (2016)

A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices
por: van der Palen, Job, et al.
Publicado: (2017)

Choosing the right inhaler for your asthma or COPD patient
por: Usmani, Omar S
Publicado: (2019)

Control in asthma and COPD – correct inhaler technique is crucial
por: Irusen, E M
Publicado: (2019)

Comorbid conditions as predictors of mortality in severe COPD – an eight-year follow-up cohort study
por: Eliason, Gabriella, et al.
Publicado: (2023)

Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
por: Andreas, Stefan, et al.
Publicado: (2016)

The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients
por: Darbà, Josep, et al.
Publicado: (2015)

On Inhaling the Smoke of Datura in Asthma
por: Christie, Thomas
Publicado: (1811)

Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
por: Janson, Christer
Publicado: (2020)

LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use
por: Boryushkina, Varvara, et al.
Publicado: (2020)

Development of the Assessment of Burden of COPD tool: an integrated tool to measure the burden of COPD
por: Slok, Annerika H M, et al.
Publicado: (2014)

Role of Inhaled Steroids in Vascular Airway Remodelling in Asthma and COPD
por: Chetta, Alfredo, et al.
Publicado: (2012)

Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for Asthma and COPD Patients
por: Plaza, Vicente, et al.
Publicado: (2016)

Effective respiratory management of asthma and COPD and the environmental impacts of inhalers
por: Usmani, Omar S., et al.
Publicado: (2023)

Impact of patient characteristics, education and knowledge on emergency room visits in patients with asthma and COPD: a descriptive and correlative study
por: Emtner, Margareta, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_kkm7380c4v4su7dkouc4607d8g